Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Description of the Changes of Ocular Perfusion in Patients with Age-related Maculopathy or Diabetic Macula Edema After Intravitreal Aflibercept Injection Treatment

NCT06878573 is registered in ClinicalTrials.gov with Augenabteilung Allgemeines Krankenhaus Linz as lead sponsor.

NCT NCT06878573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06878573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Description of the Changes of Ocular Perfusion in Patients with Age-related Maculopathy or Diabetic Macula Edema After Intravitreal Aflibercept Injection Treatment
Lead sponsor
Augenabteilung Allgemeines Krankenhaus Linz
Phase
Observational
Overall status
Completed
Start date
November 22, 2023
Completion date
July 30, 2024
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration, diabetic macular edema